The products were distributed to about 32 U.S. practitioners and were intended for office use. The recall applies only to the 10 mL vials.
Using a non-sterile product could cause site-specific or systemic infection and could lead to hospitalization, significant morbidity or death, the FDA warned. No adverse events related to this recall have been reported.
Practitioners with the recalled lots should stop using the products and either return them to Viatrexx or discard them.
Read the full news release here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
